Hematology

Neuro-Oncology

Questions discussed in this category

How do you interpret CSF pleocytosis in the context of significant leukocytosis on CBC?

For example, a patient with 100 WBCs in CSF with a peripheral WBC 43k/mm3 due to AML.

How do you time CSF analysis for suspected CNS lymphoma in patients who are on steroids?

How do different inflammatory markers like CRP and ferritin contribute differently, if at all, to the monitoring of CART neurotoxicity?

1 Answer available

How would you manage a primary dural low-grade lymphoma?

Would you consider observation following surgical resection with negative margins? Would you recommend WBRT and/or ISRT? What would be your preferred ...

2 Answers available

How would you approach treatment in a patient with Fanconi anemia and glioblastoma?

1 Answer available

How do you decide on the modality of consolidative treatment after a CR in primary CNS lymphoma patients treated with a high-dose methotrexate regimen?

How do you decide between WBRT, maintenance chemotherapy, or stem cell transplantation?

2 Answers available

Papers discussed in this category

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013-09-01

Intensive chemotherapy and immunotherapy in patients with newly diagnosed primary CNS lymphoma: CALGB 50202 (Alliance 50202).

Leukemia & lymphoma, 2017-04

Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences.

Hematology

Neuro-Oncology

Questions discussed in this category

Papers discussed in this category

Related Topics in Hematology